APLM
Price
$20.14
Change
+$3.62 (+21.91%)
Updated
Nov 13, 04:54 PM (EDT)
Capitalization
35.41M
Intraday BUY SELL Signals
IPHA
Price
$1.80
Change
-$0.12 (-6.25%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
182.14M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs IPHA

Header iconAPLM vs IPHA Comparison
Open Charts APLM vs IPHABanner chart's image
Apollomics
Price$20.14
Change+$3.62 (+21.91%)
Volume$400
Capitalization35.41M
Innate Pharma SA
Price$1.80
Change-$0.12 (-6.25%)
Volume$1.11K
Capitalization182.14M
APLM vs IPHA Comparison Chart in %
APLM
Daily Signal:
Gain/Loss:
IPHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APLM vs. IPHA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and IPHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (APLM: $16.52 vs. IPHA: $1.92)
Brand notoriety: APLM and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 3% vs. IPHA: 33%
Market capitalization -- APLM: $35.41M vs. IPHA: $182.14M
APLM [@Biotechnology] is valued at $35.41M. IPHA’s [@Biotechnology] market capitalization is $182.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileIPHA’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • IPHA’s FA Score: 1 green, 4 red.
According to our system of comparison, APLM is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 4 TA indicator(s) are bullish while IPHA’s TA Score has 4 bullish TA indicator(s).

  • APLM’s TA Score: 4 bullish, 5 bearish.
  • IPHA’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, APLM is a better buy in the short-term than IPHA.

Price Growth

APLM (@Biotechnology) experienced а +35.86% price change this week, while IPHA (@Biotechnology) price change was +5.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

IPHA is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHA($182M) has a higher market cap than APLM($35.4M). APLM YTD gains are higher at: 69.436 vs. IPHA (4.348).
APLMIPHAAPLM / IPHA
Capitalization35.4M182M19%
EBITDA-56.38MN/A-
Gain YTD69.4364.3481,597%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/AN/A-
Total Debt4.72MN/A-
FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMIPHA
RSI
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 18 days ago
73%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
IPHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DIGTF0.02N/A
N/A
Thruvision Group PLC
HNSPF5.00N/A
N/A
Hansoh Pharmaceutical Group Co Ltd.
SLFPF2.57N/A
N/A
ABERDEEN GROUP PLC
WTBFA585.00N/A
N/A
W.T.B. Financial Corp.
MTWO0.10N/A
-1.00%
M2i Global, Inc.

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
+7.90%
SNTI - APLM
47%
Loosely correlated
+3.28%
MGX - APLM
37%
Loosely correlated
-15.45%
IPHA - APLM
36%
Loosely correlated
-10.28%
HCWB - APLM
34%
Loosely correlated
-8.13%
QSI - APLM
34%
Loosely correlated
-3.80%
More

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-10.28%
MDGL - IPHA
43%
Loosely correlated
-2.32%
APLM - IPHA
36%
Loosely correlated
+7.90%
SLNO - IPHA
34%
Loosely correlated
-1.99%
VALN - IPHA
30%
Poorly correlated
+3.37%
TNXP - IPHA
30%
Poorly correlated
+1.08%
More